Harvard Pulmonary and Critical Care Medicine 2024

Description

Comprehensive Updates for State-of-the-Art Care: Evaluation, Diagnosis, Treatment, Procedures and Challenging Cases

Pulmonary and Critical Care Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies. The 2024 program will be highly interactive, providing opportunities throughout the program to pose questions online to nationally and internationally recognized leaders in their respective areas of pulmonary and critical care medicine.

OVERVIEW

This comprehensive course provides education and updates to optimize your care of patients with:

• Sepsis
• ARDS
• Sarcoidosis
• IPF
• Bronchiectasis
• Cystic fibrosis
• Lung nodules
• Lung cancer
• GERD
• Pleural disease
• Pneumonia
• Tuberculosis
• Thromboembolism
• Chronic cough
• COPD
• Asthma

• Occupational and environmental lung disease
• Interstitial lung disease
• Lung transplantation
• Neurologic issues in the ICU
• Sleep-disordered breathing
• Post-acute sequelae of COVID-19
• Surgical emergencies
• Atypical mycobacterial disease
• Pulmonary hypertension
• Cardiopulmonary disorders
• Complications from cardiac arrest
• Hypersensitivity pneumonitis
• Acute respiratory failure

REASONS TO ATTEND IN 2024

All sessions are led by master clinicians who deliver information in inspiring and entertaining ways, and provide specific recommendations to incorporate the latest updates into your practice. Education covers:

• The most current guidelines for treating sepsis
• Evidence-based treatment of ARDS
• State of the art in interventional pulmonology
• High-flow oxygen therapy for respiratory failure
• Updates on biologics in asthma and other lung disease
• New concepts in the use of vasopressors in septic shock
• New drugs and combinations in pulmonary hypertension
• New evidence on sedation, analgesia, and early mobility
• Point-of-care pulmonary ultrasound in the intensive care unit
• Lung microbiome: emerging implications for lung health
• Emerging evidence for targeted temperature management
• Evaluating occupational and environmental lung disease
• Steroid-sparing agents for interstitial lung disease
• Pulmonary embolus: the latest treatment strategies
• State-of-the-art management of the critically ill patient
• Guidance to conduct end-of-life discussions
• Updates in pulmonary pathology
• New treatment options in cystic fibrosis
• Handling neurologic and surgical emergencies in the medical ICU
• New approaches that improve outcomes for patients with unexplained chronic cough

Topics And Speakers:

Sunday, April 28, 2024

Morning Program

7:45 am to 8:00 am

Welcome

David J. Kanarek, MD

8:00 am to 8:40 am

GERD in Pulmonology

David J. Kanarek, MD

8:40 am to 9:20 am

Lung Transplantation 2024: Referral, Patient Selection, Lung Allocation, and COVID

Brian Keller, MD

9:20 am to 10:00 am

New Approaches to the Unexplained Chronic Cough

Kai Saukkonen, MD

10:00 am to 10:10 am

Break

10:10 am to 10:50 am

Occupational and Environmental Lung Disease

David Christiani, MD

10:50 am to 11:30 am

Cystic Fibrosis: Understanding CFTR and New Treatment

Isabel Neuringer, MD

11:30 am to 12:10 pm

Beyond Cystic Fibrosis: Diagnosis and Management of Non-CF Bronchiectasis

Christopher Richards, MD

12:10 pm to 1:10 pm

Q & A Session with Speakers

Drs. Christiani, Kanarek, Keller, Lai, Neuringer, Richards, Saukkonen, and Angela Frank, MD, MPH

1:10 pm to 2:00 pm

Break

Afternoon Program

2:00 pm to 2:40 pm

Pulmonary Pathology: Interstitial Lung Disease

Lida Hariri, MD, PhD

2:40 pm to 3:20 pm

Diagnosis and Management of IPF: When, Why, and How to Use the Newest Drugs

Sydney Montesi, MD

3:20 pm to 4:00 pm

Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD

Barry Shea, MD

4:00pm to 4:10 pm

Break

4:10 pm to 4:50 pm

Hypersensitivity Pneumonitis: Pigeons, Farmers, and Hot Tubs, Oh My!

Rachel Knipe, MD

4:50 pm to 5:30 pm

Treatment Challenges of Pulmonary Sarcoidosis

Robert Hallowell, MD

5:30 pm to 6:10 pm

Palliative Care in Advanced Lung Disease

Bethany-Rose Daubman, MD

6:10 pm to 7:10 pm

Q & A Session with Speakers

Drs. Daubman, Frank, Hallowell, Hariri, Knipe, Montesi, Shea, and Kathryn Hibbert, MD

Monday, April 29, 2024

Morning Program

8:00 am to 8:40 am

ARDS: State-of-the-Art Strategies to Protect the Lung

Kathryn Hibbert, MD

8:40 am to 9:20 am

Noninvasive Respiratory Support for Acute Respiratory Failure: Less May Not Be Best

Carolyn La Vita, MHA, RRT

9:20 am to 10:00 am

Novel Ventilator Modes: The Hype and Reality

Carolyn La Vita, MHA, RRT

10:00 am to 10:10 am

Break

10:10 am to 10:50 am

Fluid Responsiveness

David Ziehr, MD

10:50 am to 11:30 am

Vasopressors in Septic Shock: Old Friends and New

Jason Griffith, MD, PhD

11:30 am to 12:10 pm

Point-of-Care Pulmonary Ultrasound in the Intensive Care Unit

Jonah Rubin, MD

12:10 pm to 1:10 pm

Q & A with Speakers

Drs. Kanarek, North, Rubin, and Wong, and Carolyn La Vita, MHA, RRT

1:10 pm to 2:00 pm

 Afternoon Program

2:00 pm to 2:40 pm

The Legacy of COVID: A Clinical Approach to Post Acute Sequelae of COVID

Leo Ginns, MD

2:40 pm to 3:20 pm

After the ICU: Post-ICU Care Syndrome and Recovery

George Alba, MD

3:20 pm to 4:00 pm

Approach to Empiric Antibiotics in the ICU

Alyssa Letourneau, MD

4:00 pm to 4:10 pm

Break

4:10 pm to 4:50 pm

Approach to the Immunocompromised Critically Ill Patient

Lisa Bebell, MD

4:50 pm to 5:30 pm

Community-Acquired Pneumonia: The Newest Guidelines and State-of-the-Art Treatment Strategies State-of the-Art Treatment Strategies

Joshua Metlay, MD, PhD

5:30pm to 6:10pm

The Microbiome and Lung Disease

Peggy Lai, MD

6:10pm to 7:10pm

Expanded Q & A Session

Drs. Alba, Bebell, Ginns, Hibbert, Lai, Letourneau, and Metlay

Tuesday, April 30, 2024

Morning Program

8:00am to 8:40am

Common Neurologic Issues in the ICU

Sahar Zafar, MD

8:40am to 9:20am

From Ancient Egypt to Balanced Crystalloids: Medicine’s Attempts to Manage Sepsis

Eric Schmidt, MD

9:20 am to 10:00 am

Sedation, Analgesia, and Early Mobility: The State of the Art in 2024

Crystal North, MD, MPH

10:00 am to 10:10 am

Break

10:10 am to 10:50 am

TTM and Neuroprognostication after Cardiac Arrest

David Greer, MD

10:50 am to 11:30 am

Prognosis and Uncertainty in the ICU

Emily Rubin, MD

11:30 am to 12:10 pm

Surgical Emergencies in the Medical ICU

Noelle Saillant, MD

12:10 pm to 1:10 pm

Q & A with Speakers

Drs. Frank, Greer, North, Rubin, Saillant, Schmidt, and Zafar

1:10 pm to 2:00 pm

Break

Afternoon Program

2:00 pm to 2:40 pm

Thrombotic Mechanisms and Antithrombotic Agents: How Do the New Oral Agents Fit in 2024?

Rachel Rosovsky, MD, MPH

2:40 pm to 3:20 pm

Pulmonary Embolism: An Update

Alison Witkin, MD

3:20 pm to 4:00 pm

Pulmonary Hypertension: Categorization and Evaluation

Josanna Rodriguez-Lopez, MD

4:00 pm to 4:10 pm

Break

4:10 pm to 4:50 pm

Pulmonary Hypertension: Management

Alexandra “Sasha” Wong, MD

4:50 pm to 5:30 pm

Vasculitis and ANCA

John Niles, MD

5:30 pm to 6:10 pm

Exercise and Cardiopulmonary Disorders: Indications and Interpretation

1. Corey Hardin, MD, PhD

6:10 pm to 7:10 pm

Q & A with Speakers

Drs. Hardin, Hibbert, Niles, Rodriguez-Lopez, Rosovsky, Witkin, and Wong

Wednesday, May 1, 2024

Morning Program

8:00 am to 8:40 am

Pleural Disease: 2024 Updates

Fayez Kheir, MD, MSc

8:40 am to 9:20 am

Interventional Pulmonology in 2024

Erik Folch, MD

9:20 am to 10:00 am

Interventional Bronchoscopy in COPD: Valves, Coils, and Beyond

Colleen Keyes, MD, MPH

10:00 am to 11:00 am

Extended Q & A with Interventional Pulmonary Faculty

Drs. Folch, Frank, Keyes, and Kheir

11:00 am to 11:10 am

Break

11:10 am to 11:50 am

Looking Deeper: Patterns and Insights from Chest Radiology

Amita Sharma, MBBS

11:50 am to 12:30 pm

A Strategic Approach to the Management of Pulmonary Nodules

Angela Frank, MD, MPH

12:30 pm to 1:10 pm

Treatment of Non-Small Cell Lung Cancer: Traditional Chemotherapy, Targeted Therapy, and Immunotherapies

Jaime Schneider, MD, PhD

1:10 pm to 2:00 pm

Break

Afternoon Program

2:00 pm to 2:40 pm

COPD 2024

Walter O’Donnell, MD

2:40 pm to 3:20 pm

Asthma: Ensuring Your Treatment Approaches Are Current with the State of the Art

Jehan Alladina, MD

3:20 pm to 4:00 pm

New Therapeutics in Lung Disease: The Age of Immunotherapy

Benjamin Medoff, MD

4:00 pm to 4:10 pm

Break

4:10 pm to 4:50 pm

Aspergillus Lung Disease

Rod Rahimi, MD

4:50 pm to 5:30 pm

Tuberculosis in 2024

Maha Farhat, MD, MSc

5:30 pm to 6:10 pm

Non-Tuberculous Mycobacterial Disease: Navigating the Labyrinth

Rocío Hurtado, MD, DTM&H

6:10 pm to 7:10 pm

Q & A with Speakers

Drs. Alladina, Farhat, Frank, Hibbert, Hurtado, Medoff, Metlay, Montesi, O’Donnell, Schneider, and Sharma

Thursday, May 2, 2024

Morning Program: Sleep Medicine for Pulmonologists

8:00 am to 9:00 am

Obstructive Sleep Apnea

James Mojica, MD, FAASM

9:00 am to 10:00 am

Complex Sleep Apnea 2024

James Mojica, MD, FAASM

10:00am to 10:10am

Break

10:10am to 11:10am

Sleep Diagnostics

Katherine Dudley, MD

11:10am to 12:10pm

Noninvasive Ventilation

Katherine Dudley, MD

12:10pm to 12:25pm

Break

12:25pm to 1:10pm

Q & A Session

Drs. Dudley, Kanarek, and Mojica